·

Initiate ‘Thru-Septal RF ablation early feasibility clinical study for HOCM)

·

Tau Cardio Inc. (US) established

·

Series B funding (USD 22 M)

·

Selected for national R&D project (3D Leaflet TR, Thru-Septal RF ablation)

·

Series A-2 funding (USD 2.8 M)

·

‘Innobiz Company’ certification

·

MitraLoop exploratory clinical b multi-center approval (Seoul Asan Hospital and 6 other hospitals)

·

R&D Center certification

·

Selected for national R&D project (Mitral Loop Cerclage)

·

Peter Park joined as a new management (CEO)

·

‘Venture Company’ certification

·

Series A funding (USD 4.4 M)

·

Initiate ‘Mitra Loop Cerclage exploratory clinical study for MR)

·

Medical Device GMP Conformity Assessment Conformance Certification

·

Tau-PNU Medical Inc. established

·

‘Research Institute Company’ certification

·

GMP facility construction completed